Preferred Pharmaceuticals, Inc recalls Losartan Potassium Tab. USP 50mg, a) 30 count bottle (NDC 68788-0048-03) and b) 90 count bottle (NDC 68788-0048-09), Rx
Preferred Pharmaceuticals recalls 50mg Losartan Potassium tablets due to FDA-confirmed impurity NMBA above safe levels. Consumers should check NDC codes and contact the company for details.
Recall notice
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
Contact the company & request your remedy
What happened, in plain English
Preferred Pharmaceuticals is recalling two types of 50mg Losartan Potassium tablets because FDA tests found an impurity (NMBA) in the product at levels above the acceptable daily intake. This impurity could pose a health risk if taken regularly. Read more at govinfonow.com/recall/38870-preferred-pharmaceuticals-losartan-50mg-tablets-recall-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/38870-preferred-pharmaceuticals-losartan-50mg-tablets-recall-impurity-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1281-2019
Cite this page
“Preferred Pharmaceuticals Losartan 50mg Tablets Recall: Impurity Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38870-preferred-pharmaceuticals-losartan-50mg-tablets-recall-impurity-risk. Based on FDA recall #D-1281-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1281-2019%22&limit=1).
Why it’s dangerous
The FDA confirmed the presence of N-Methylnitrosobutyric acid (NMBA) in the tablets at levels exceeding the safe daily intake. This impurity could cause health issues if taken regularly, though the exact risk level isn't specified in the recall.
Who’s affected
People who have the 30-count or 90-count bottles of 50mg Losartan Potassium tablets (NDC 68788-0048-03 or 68788-0048-09) prescribed by a doctor. Those taking this medication for blood pressure are most at risk.
How to tell if you have this one
Check for the 30-count or 90-count bottles labeled 'Losartan Potassium Tab. USP 50mg' with NDC codes 68788-0048-03 or 68788-0048-09. These are prescription-only products sold by Preferred Pharmaceuticals.
- Brand
Preferred Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC codes 68788-0048-03 or 68788-0048-09 on the bottle label to confirm if your product is recalled.
Questions people ask
Is this product safe to take?
The FDA confirmed the presence of an impurity (NMBA) in the product at levels above the acceptable daily intake, but the exact health risk isn't specified in the recall notice.
How do I know if I have the recalled product?
Check for the 30-count or 90-count bottles labeled 'Losartan Potassium Tab. USP 50mg' with NDC codes 68788-0048-03 or 68788-0048-09.
What should I do if I have the recalled product?
The recall notice does not specify a remedy, so contact Preferred Pharmaceuticals directly for guidance.
Contact Preferred Pharmaceuticals
We’ve drafted a message you can send Preferred Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-1281-2019 — Preferred Pharmaceuticals Preferred Pharmaceuticals Hello, I own a Preferred Pharmaceuticals that is covered by recall D-1281-2019 from Preferred Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1281-2019 (April 30, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1281-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.